![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Franklin, Cindy 
ORCID: https://orcid.org/0000-0001-9142-5423; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick ORCID: https://orcid.org/0000-0002-5894-1677; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea ORCID: https://orcid.org/0000-0002-6185-4945; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander ORCID: https://orcid.org/0000-0003-2275-499X; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo ORCID: https://orcid.org/0000-0001-7862-3695; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike ORCID: https://orcid.org/0000-0003-2864-4273; Helfrich, Iris; Roesch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne und Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704
(2022):
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 6, e004509
ORCID: https://orcid.org/0000-0001-9142-5423; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick ORCID: https://orcid.org/0000-0002-5894-1677; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea ORCID: https://orcid.org/0000-0002-6185-4945; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander ORCID: https://orcid.org/0000-0003-2275-499X; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo ORCID: https://orcid.org/0000-0001-7862-3695; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike ORCID: https://orcid.org/0000-0003-2864-4273; Helfrich, Iris; Roesch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne und Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704
(2022):
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 6, e004509
Amaral, Teresa; Kiecker, Felix; Schaefer, Sarah; Stege, Henner; Kaehler, Katharina; Terheyden, Patrick; Gesierich, Anja; Gutzmer, Ralf; Haferkamp, Sebastian; Uttikal, Jochen; Berking, Carola; Rafei-Shamsabadi, David; Reinhardt, Lydia; Meier, Friedegund; Karoglan, Ante; Posch, Christian; Gambichler, Thilo; Pfoehler, Claudia; Thoms, Kai; Tietze, Julia; Debus, Dirk; Herbst, Rudolf; Emmert, Steffen; Loquai, Carmen; Hassel, Jessica C.; Meiss, Frank; Tueting, Thomas; Heinrich, Vanessa; Eigentler, Thomas; Garbe, Claus und Zimmer, Lisa
(2020):
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.
In: Journal for Immunotherapy of Cancer, Bd. 8, Nr. 1, e000333
[PDF, 840kB]
Knispel, Sarah; Stang, Andreas; Zimmer, Lisa; Lax, Hildegard; Gutzmer, Ralf; Heinzerling, Lucie; Weishaupt, Carsten; Pfoehler, Claudia; Gesierich, Anja; Herbst, Rudolf; Kaehler, Katharina C.; Weide, Benjamin; Berking, Carola; Loquai, Carmen; Utikal, Jochen; Terheyden, Patrick; Kaatz, Martin; Schlaak, Max; Kreuter, Alexander; Ulrich, Jens; Mohr, Peter; Dippel, Edgar; Livingstone, Elisabeth; Becker, Jürgen C.; Weichenthal, Michael; Chorti, Eleftheria; Gronewold, Janine; Schadendorf, Dirk und Ugurel, Selma
(2020):
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
In: Journal for Immunotherapy of Cancer, Bd. 8, Nr. 1, e000395
Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert H.; Berking, Carola; Sunderkoetter, Cord; Kaatz, Martin; Schatton, Kerstin; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Verver, Danielle; Martus, Peter und Garbe, Claus
(2019):
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
In: Journal of Clinical Oncology, Bd. 37, Nr. 32
Heppt, Markus V.; Heinzerling, Lucie; Kähler, Katharina C.; Forschner, Andrea; Kirchberger, Michael C.; Loquai, Carmen; Meissner, Markus; Meier, Friedegund; Terheyden, Patrick; Schell, Beatrice; Herbst, Rudolf; Göppner, Daniela; Kiecker, Felix; Rafei-Shamsabadi, David; Haferkamp, Sebastian; Huber, Margit A.; Utikal, Jochen; Ziemer, Mirjana; Bumeder, Irmgard; Pfeiffer, Christiane; Schäd, Susanne G.; Schmid-Tannwald, Christoph; Tietze, Julia K.; Eigentler, Thomas K. und Berking, Carola
(2017):
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
In: European Journal of Cancer, Bd. 82: S. 56-65
Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert; Berking, Carola; Sunderkötter, Cord; Kaatz, Martin; Schulte, Klaus-Werner; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Martus, Peter und Garbe, Claus
(2016):
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 17, Nr. 6: S. 757-767